Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease

International Journal of Cardiology

Volumn 90, Issue 2-3, 2003, Pages 219-227

  Falcone, C ^a   Nespoli, L ^a   Geroldi, D ^a   Gazzaruso, C ^b   Buzzi, M P ^a   Auguadro, C ^a   Tavazzi, L ^a   Schwartz, P J ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b IRCCS   (Italy)

Author keywords

Coronary artery disease; Diabetes mellitus; Silent myocardial ischemia

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DAILY LIFE ACTIVITY; DIABETES MELLITUS; EXERCISE TEST; FEMALE; GENDER; HEART MUSCLE ISCHEMIA; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SILENT MYOCARDIAL INFARCTION; ST SEGMENT DEPRESSION; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; WORKLOAD;

EID: 0041382429     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00558-2     Document Type: Article

References (60)

1. Wilson P.W. Diabetes mellitus and coronary heart disease. Am J Kidney Dis. 32:1998;S89-S100.
2. McGill H.C. Jr., McMahan C.A. Determinants of atherosclerosis in the young: pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am J Cardiol. 82:1998;30T-36T.
3. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation. 97:1998;1837-1847.
4. Grundy S.M., Benjamin I.J., Burke G.L., et al. Diabetes and cardiovascular disease: a statement for health professionals from the American Heart Association. Circulation. 100:1999;1134-1146.
5. Haffner S.M., Letho S., Rönnemaa T., Pyörälä K., Laakso M. Mortality from coronary artery disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New Engl J Med. 339:1998;229-234.
6. Uusitupa M., Niskanen L.K., Siitonen O., Voutilainen E., Pyorala K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type-2 (non insulin-dependent) diabetic subjects. Diabetologia. 59:1993;8-13.
7. Stamler J., Vaccaro O., Neaton J.D., Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 16:1993;434-444.
8. Nesto R.W., Philllips R.T. Asymptomatic myocardial ischemia in diabetic patients. Am J Med. 80:(suppl 4C):1986;40-47.
9. Weitzman S., Wagner G.S., Heiss G., Haney T.L., Sloman G. Myocardial infarction site and mortality in diabetes. Diabetes Care. 5:1982;31-35.
10. Margolis J.R., Kannel W.B., Feinleib M., Dowber T.R., McNamara P.M. Clinical features of unrecognized myocardial infarction. Silent and asymptomatic. Eighteen year follow-up: The Framingham Study. Am J Cardiol. 32:1973;1-7.
11. Koistinen M.J. Prevalence of asymptomatic myocardial ischemia in diabetic subjects. Br Med J. 301:1990;92-95.
12. Scheidt-Nave C., Barrett-Connor E., Wingar D.L. Resting electrocardiographic abnormalities suggestive of asymptomatic ischemic heart disease associated with non-insulin dependent diabetes mellitus in a defined population. Circulation. 81:1990;899-906.
13. Langer A., Freeman M.R., Josse R.G., Steiner G., Armstrong P.W. Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol. 67:1991;1073-1078.
14. Janand-Delenne B., Savin B., Habib G., Bory M., Vague P., Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes. Diabetes Care. 22:(9):1999;1396-1400.
15. Fazzini P.F., Prati P., Rovelli F.L., et al. Epidemiology of silent myocardial ischemia in asymptomatic middle-aged men (The ECCIS project). Am J Cardiol. 72:1993;1383-1388.
16. Chipkin S.R., Frid D., Alpert J.S., Baker S.P., Dalen J.E., Aronin N. Frequency of painless myocardial ischemia during exercise testing in patients with and without diabetes mellitus. Am J Cardiol. 59:1987;61-65.
17. Cohn P.F. Silent myocardial ischemia classification, prevalence and prognosis. Am J Med. 79:(3A):1985;2-6.
18. Falcone C., De Servi S., Poma E., et al. Clinical significance of exercise-induced silent ischemia in patients with coronary artery disease. J Am Coll Cardiol. 9:(2):1987;295-299.
19. Weiner D.A., McCabe C., Heuter D.C., Ryan T.J., Hood W.B. Jr. The predictive value of angina chest pain as an indicator of coronary disease during exercise testing. Am Heart J. 96:1978;458-462.
20. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Geneva: World Health Organisation, 1985 (Tech. Rep. Ser., No. 727).
21. Schlaut R.C., Blomquist C.G., Brandeburg R.O., et al. Guidelines for exercise testing. A report of the joint American College of Cardiology/American Heart Association Task Force on assessment of cardiovascular procedures (Subcommittee on Exercise Testing). Circulation. 74:1986;63a.
22. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Prevalence of unrecognised silent myocardial ischemia and its association with atherosclerotic risk factors in non insulin-dependent diabetes mellitus. Am J Cardiol 1997;79:134-9.
23. Rutter M.K., McComb J.M., Brady S., Marshall S.M. Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non-insulin-dependent diabetes mellitus. Am J Cardiol. 83:1999;27-31.
24. Nesto R.W. Screening for asymptomatic coronary artery disease in diabetes. Diabetes Care. 22:(9):1999;1393-1395.
25. Paillole C., Ruiz J., Juliard J.M., Leblanch H., Gourgon R., Passa P. Detection of coronary artery disease in diabetic patients. Diabetologia. 38:1995;726-731.
26. Bradley R.F., Schonefeld A. Diminished pain in diabetic patients with acute myocardial infarction. Geriatrics. 17:1962;322-326.
27. Patarmian J.O., Bradley R.F. Acute myocardial infarction in 285 cases of diabetes. Immediate mortality and five-year survival. New Engl J Med. 273:1965;455-461.
28. Soler N.G., Bennett M.A., Pentecost B.L., Fitzgerald M.G., Malins J.M. Myocardial infarction in diabetics. Q J Med. 44:1975;125-132.
29. Ewing D.J., Martyn C.N., Young R.J., Clarke B.F. The value of cardiovascular autonomic function tests: 10 year experience in diabetes. Diabetes Care. 8:1985;491-498.
30. Rosenmann. Painless myocardial infarction: review of the literature and the analysis of 220 cases. Ann Intern Med 1954;41:1-3.
31. Chiariello M, Indolfi C, Condorelli M. La cardiopatia ischemica silente nel diabetico. In: Prati PL, editor. Cardiopatia ischemica silente. Firenze 1982;283-90.
32. Lochen M.L. The Tromso study: the prevalence of exercise-induced silent myocardial ischemia and relation to risk factors for coronary artery disease in an apparently healthy population. Eur Heart J. 13:1992;728-731.
33. Stuart R., Chipkin S.R., Gottlieb P., Lundstrom R., Leppo J., Aronin N. Transient myocardial perfusion abnormalities in diabetic patients: a prospective study using thallium exercise tolerance testing. Cardiology. 79:1991;172-179.
34. Nesto R.W., Phillips R.T., Kett K.G., et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med. 108:1988;170-175.
35. Hinzel H.O., Leutwyler R., Krayenbuehl H.P. Silent myocardial ischemia: haemodynamic changes during dynamic exercise in patients with proven coronary artery disease despite absence of angina pectoris. J Am Coll Cardiol. 6:1985;275-284.
36. Lindsey H.E., Cohn P.F. 'Silent' myocardial ischemia during and after exercise testing in patients with coronary artery disease. Am Heart J. 95:1978;441-445.
37. Naka M., Hiramatsu K., Aizawa T., et al. Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J. 123:1992;46-53.
38. Nesto P.W., Watson F.S., Kowalchuck G.J., et al. Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dipiridamole thallium-201 scintigraphy. Am Heart J. 120:1990;1073-1077.
39. Bernardi L., Ricordi L., Lazzari P., et al. Impaired circadian modulation of sympathovagal activity in diabetes: a possible explanation for altered temporal onset of cardiovascular disease. Circulation. 86:(5):1992;1443-1452.
40. O'Brien I.A., O'Hare P., Corral R.J.M. Heart rate variability in healthy subjects: effect of age and the derivation of normal ranges for tests of autonomic function. Br Heart J. 55:1986;348-354.
41. Ewing D.J., Clarke B.F. Diagnosis and management of diabetic autonomic neuropathy. Br Med J. 285:1982;916-918.
42. Ambepityia G., Kopelman P.G., Ingram D., Swash M., Millis P.G., Timmis A.D. Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function. J Am Coll Cardiol. 15:1990;72-77.
43. Hume L., Oakley G.D., Boulton J.M., Hardisty C., Ward J.D. Asymptomatic myocardial ischemia in diabetes and its relationship to diabetic neuropathy: an exercise electrocardiography study in middle-aged diabetic men. Diabetes Care. 9:1986;384-388.
44. Hilsted J., Galbo H., Christensen N.J., Parving H.H., Benn J. Haemodynamic changes during graded exercise in patients with diabetic autonomic neuropathy. Diabetologia. 22:1982;318-323.
45. Bennet T., Farquhar I.K., Hosking D.J., Hampton J.R. Assessment of methods for estimating nervous control of the heart in patients with diabetes mellitus. Diabetes. 27:1978;1167-1174.
46. Bernard C. Leçons sur le diabete et la glyconeogeneses animal. Paris: Bailliere, 1877.
47. Valensi P., Sachs R.-N., Harfouche B., et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with and without silent myocardial ischemia. Diabetes Care. 4:2001;339-343.
48. Valensi P., Huart J.P., Giroux Ch., Attali J.R. Factors involved in cardiac autonomic neuropathy in diabetic patients. J Diabetes Complications. 11:1997;180-187.
49. Valensi P., Attali J.R. Why and how should cardiovascular neuropathy in the diabetic patients be researched? Diabetes Metab. 23:1997;351-356.
50. Valensi P. Diabetic autonomic neuropathy: what are the risks? Diabetes Metab. 24:(3):1998;66-72.
51. Faerman I., Faccia E., Milei J., et al. Autonomic neuropathy and painless myocardial infarctions in diabetic patients. Diabetes. 26:1977;1147-1158.
52. Droste C., Roskamm H. Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol. 1:1983;940-945.
53. Cohn P.F. Silent myocardial ischemia in patients with a defective anginal warning system. Am J Cardiol. 45:1980;697-702.
54. van Rijn T., Rablum S.W. Effect of naloxone, a specific opioid antagonist on exercise-induced angina pectoris (abstract). Circulation. 64:(IV):1981;149-560.
55. Ellestead M.H., Peiliang K. Naloxone and asymptomatic ischemia: failure to induce angina during exercise testing. Am J Cardiol. 54:1984;982-984.
56. Falcone C., Sconocchia R., Guasti L., Codega S., Montemartini C., Specchia G. Dental pain threshold and angina pectoris in patients with coronary artery disease. J Am Coll Cardiol. 12:(2):1988;348-352.
57. Giubbini R., Galli M., Campini R., Bosimini E., Bencivelli W., Tavazzi L. Effects of mental stress on myocardial perfusion in patients with ischemic heart disease. Circulation. 83:(II):1991;100-107.
58. Freeman L.J., Nixon P.G., Sallabank P., Reaveley D. Psychological stress and silent myocardial ischemia. Am Heart J. 114:1987;477-482.
59. Falcone C., Auguadro C., Pistorio A., Catalano O., Angoli L., Specchia G. Mental status and pain perception during stressor tests in patients with coronary artery disease. Eur J Pain. 1:1997;123-183.
60. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998;21:1551-59.